Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 24, Issue 2, Pages 91-100
Publisher
Informa UK Limited
Online
2020-01-31
DOI
10.1080/14728222.2020.1724285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Migraine-provoking substances evoke periorbital allodynia in mice
- (2019) Francesco De Logu et al. JOURNAL OF HEADACHE AND PAIN
- Gepants for the treatment of migraine
- (2019) Andrea Negro et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models
- (2019) Amanda Avona et al. JOURNAL OF NEUROSCIENCE
- Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial
- (2019) David W Dodick et al. CEPHALALGIA
- Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
- (2019) Messoud Ashina et al. CEPHALALGIA
- Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls
- (2019) Katharina Kamm et al. CEPHALALGIA
- Ischemic Stroke Associated With Calcitonin Gene-Related Peptide Inhibitor Therapy for Migraine: A Case Report
- (2019) Stephen Aradi et al. Journal of Stroke & Cerebrovascular Diseases
- Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
- (2019) Robert Croop et al. LANCET
- Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
- (2019) Richard B. Lipton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fremanezumab for the preventive treatment of migraine in adults
- (2019) Luana Lionetto et al. Expert Review of Clinical Pharmacology
- Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults
- (2019) Peter J Goadsby et al. CEPHALALGIA
- Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine
- (2019) Richard B. Lipton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system
- (2019) Jacob C. A. Edvinsson et al. JOURNAL OF HEADACHE AND PAIN
- Ubrogepant for the Treatment of Migraine
- (2019) David W. Dodick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2018) Messoud Ashina et al. CEPHALALGIA
- A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects
- (2018) Orit Cohen-Barak et al. CEPHALALGIA
- Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials
- (2018) Rashmi B Halker Singh et al. CEPHALALGIA
- Molecular studies of CGRP and the CGRP family of peptides in the central nervous system
- (2018) Erica R Hendrikse et al. CEPHALALGIA
- Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study
- (2018) Tina Marie Myers Oakes et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
- (2018) Christophe Depre et al. HEADACHE
- The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies
- (2018) Rebecca Burch et al. HEADACHE
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
- (2018) Karl Messlinger JOURNAL OF HEADACHE AND PAIN
- PACAP and its role in primary headaches
- (2018) Lars Edvinsson et al. JOURNAL OF HEADACHE AND PAIN
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- The serum level of inflammatory markers in chronic and episodic migraine: a case-control study
- (2018) Fahimeh Martami et al. NEUROLOGICAL SCIENCES
- Peripherally Administered CGRP Induces Spontaneous Pain in Mice
- (2018) Brandon J. Rea et al. PAIN
- The Parabrachial Nucleus: CGRP Neurons Function as a General Alarm
- (2018) Richard D. Palmiter TRENDS IN NEUROSCIENCES
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention
- (2018) Vladimir Skljarevski et al. JAMA Neurology
- Encoding of danger by parabrachial CGRP neurons
- (2018) Carlos A. Campos et al. NATURE
- Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
- (2018) Casper Emil Christensen et al. JOURNAL OF HEADACHE AND PAIN
- Overview of Neuropeptides: Awakening the Senses?
- (2017) Andrew F. Russo HEADACHE
- Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines
- (2017) Joshua M. Cohen et al. HEADACHE
- CGRP and its receptors
- (2017) Debbie L. Hay et al. HEADACHE
- Functional and structural alterations in the migraine cerebellum
- (2017) Jan Mehnert et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- A craniofacial-specific monosynaptic circuit enables heightened affective pain
- (2017) Erica Rodriguez et al. NATURE NEUROSCIENCE
- Activity and connectivity of the cerebellum in trigeminal nociception
- (2017) Jan Mehnert et al. NEUROIMAGE
- Erenumab (AMG 334) in episodic migraine
- (2017) Messoud Ashina et al. NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission
- (2017) Rebecca E. Yarwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
- (2017) David Monteith et al. Frontiers in Pharmacology
- Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis
- (2016) Robin M van Dongen et al. CEPHALALGIA
- A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
- (2016) Tiffini Voss et al. CEPHALALGIA
- Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms
- (2016) Bianca N. Mason et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- TEV-48125 for the preventive treatment of chronic migraine
- (2016) Marcelo E. Bigal et al. NEUROLOGY
- Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
- (2016) Song Guo et al. PAIN
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
- (2015) Andrew F. Russo Annual Review of Pharmacology and Toxicology
- CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
- (2015) Lars Edvinsson BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine
- (2015) Tony W Ho et al. CEPHALALGIA
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Role of PACAP in migraine headaches
- (2014) László Vécsei et al. BRAIN
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Altered processing of sensory stimuli in patients with migraine
- (2014) Marina de Tommaso et al. Nature Reviews Neurology
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
- (2014) T. W. Ho et al. NEUROLOGY
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- The role of the blood–brain barrier in the development and treatment of migraine and other pain disorders
- (2014) Marcos F. DosSantos et al. Frontiers in Cellular Neuroscience
- Migraine and the Risk for Stroke and Cardiovascular Disease
- (2014) Simona Sacco et al. Current Cardiology Reports
- Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
- (2013) Marcelo E Bigal et al. CEPHALALGIA
- The effect of sodium nitroprusside on cerebral hemodynamics and headache in healthy subjects
- (2013) Song Guo et al. CEPHALALGIA
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
- (2013) Ronald Marcus et al. CEPHALALGIA
- Unanswered Questions in Headache: So What Is Photophobia, Anyway?
- (2013) Andrew F. Russo et al. HEADACHE
- Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
- (2013) E. Cernuda-Morollon et al. NEUROLOGY
- CGRP and migraine: Could PACAP play a role too?
- (2013) Eric A. Kaiser et al. NEUROPEPTIDES
- Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level
- (2012) Sajedeh Eftekhari et al. BMC NEUROSCIENCE
- The Evolution of a Migraine Attack - A Review of Recent Evidence
- (2012) Andrew Charles HEADACHE
- Modulation of CGRP-Induced Light Aversion in Wild-Type Mice by a 5-HT1B/D Agonist
- (2012) E. A. Kaiser et al. JOURNAL OF NEUROSCIENCE
- Light Evokes Melanopsin-Dependent Vocalization and Neural Activation Associated with Aversive Experience in Neonatal Mice
- (2012) Anton Delwig et al. PLoS One
- Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
- (2011) Faisal Mohammad Amin et al. CEPHALALGIA
- Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
- (2011) David J Hewitt et al. CEPHALALGIA
- Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation
- (2011) Ann C. Raddant et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Randomized Controlled Study of Telcagepant Plus Ibuprofen or Acetaminophen in Migraine
- (2011) David J. Hewitt et al. HEADACHE
- Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine
- (2011) Ertugrul Uzar et al. JOURNAL OF HEADACHE AND PAIN
- Evidence for a vascular factor in migraine
- (2010) Mohammad S. Asghar et al. ANNALS OF NEUROLOGY
- Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus
- (2010) O. Summ et al. BRAIN
- BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
- (2010) Hans-Christoph Diener et al. CEPHALALGIA
- Randomized, controlled trial of telcagepant over four migraine attacks
- (2010) Andrew P Ho et al. CEPHALALGIA
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
- (2010) Jakob Møller Hansen et al. CEPHALALGIA
- Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
- (2010) Kathryn M. Connor et al. HEADACHE
- Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
- (2010) K. Y. Chan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat
- (2010) Lars Edvinsson et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Coding of facial expressions of pain in the laboratory mouse
- (2010) Dale J Langford et al. NATURE METHODS
- A neural mechanism for exacerbation of headache by light
- (2010) Rodrigo Noseda et al. NATURE NEUROSCIENCE
- Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion
- (2010) S. Eftekhari et al. NEUROSCIENCE
- CGRP receptor antagonism and migraine
- (2010) Lars Edvinsson et al. Neurotherapeutics
- Regulation of signal transduction by calcitonin gene-related peptide receptors
- (2010) Christopher S Walker et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan
- (2009) Roger K. Cady et al. HEADACHE
- Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
- (2009) A. Recober et al. JOURNAL OF NEUROSCIENCE
- Genetic Enhancement of Calcitonin Gene-Related Peptide-Induced Central Sensitization to Mechanical Stimuli in Mice
- (2009) Blanca Marquez de Prado et al. JOURNAL OF PAIN
- Randomized, controlled trial of telcagepant for the acute treatment of migraine
- (2009) K. M. Connor et al. NEUROLOGY
- Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP
- (2009) Ana Recober et al. NEUROPHARMACOLOGY
- The Blood-Brain Barrier in Migraine Treatment
- (2008) L Edvinsson et al. CEPHALALGIA
- Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine
- (2008) A Rahmann et al. CEPHALALGIA
- Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
- (2008) Tony W Ho et al. LANCET
- Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
- (2007) L Edvinsson et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search